Management Board

Chief Executive Officer at Captor Therapeutics. 30 years’ experience of Biotech senior management in the UK, USA, France, Switzerland, Australia and Poland, leading 12 major license agreements, 6 private investor rounds and 3 IPOs.
Awarded a PhD in biochemistry from Strathclyde University, Glasgow, and CEP diploma from the London Business School. Keen amateur musician and enjoys hiking, sailing, skiing and photography.

Michał Walczak is a Chief Scientific officer, CSO, responsible for R&D and strategy. He obtained a PhD degree from the Swiss Federal Institute of Technology in Zurich , ETH Zurich, and studied at the University of Wroclaw and University of Virginia. He completed his postdoctoral training at the Friedrich Miescher Institute for Biomedical Research in Basel, which is a part of Novartis Institutes for Biomedical Research. Roles played by the member of the Management Board in other companies: Not applicable.